Home Newsfeeds Raymond James Downgrades Duck Creek Technologies to Market Perform

Raymond James Downgrades Duck Creek Technologies to Market Perform

Raymond James analyst Alexander Sklar downgrades Duck Creek Technologies (NASDAQ:DCT) from Outperform to Market Perform.

byBenzinga Newsdesk

January 17, 2023

1 minute read

Raymond James analyst Alexander Sklar downgrades Duck Creek Technologies (NASDAQ:DCT) from Outperform to Market Perform.

Bionano Announces Full Commercial Release Of The Stratys System For High Throughput Optical Genome Mapping

By Benzinga Newsdesk

January 23, 9:13 AM

Bionano has completed the early access program for the Stratys™ system and is now making it available in a full commercial release The Stratys instrument can enable up to a four-fold increase in raw data

BNGO

Opioid Developer Ensysce Biosciences Stock Is Shooting Higher Today – Here’s Why

By Vandana Singh

January 23, 2:13 PM

Ensysce Biosciences breakthrough in opioid innovation! FDA grants PF614-MPAR BTD for enhanced pain relief with overdose protection. Learn more about this cutting-edge drug.

ENSC

Cybin Announces Grant Of U.S. Patent Covering Proprietary Deuterated Psilocybin Analog In Its CYB003 Program

By Happy Mohamed

August 15, 8:00 AM

- Newly granted U.S. patent covers composition of matter claims and treatment methods in support of the Company's CYB003 program until 2041 - - Company's intellectual property portfolio now encompasses 2 granted

CYBN